Professor Li-Sheng Zhang earned his B.S. in Materials Chemistry from Peking University. He then completed his Ph.D. in Chemistry at The University of Chicago in 2019, with the support of the HHMI International Student Research Fellowship. During his Ph.D. training, Li-Sheng discovered ALKBH7-mediated reversible RNA methylation in mitochondrial polycistronic RNA, which regulates mitochondrial gene expression. During his postdoc training, Li-Sheng developed a suite of base-resolution quantitative sequencing methods to study various RNA modifications, as the first- or corresponding authors: (1) Bisulfite-Induced Deletion sequencing (BID-seq, Nature Biotechnology (2023)) for mapping mRNA Ψ; (2) Ultralow-background BID-seq (Nature Protocols (2023)); (3) Nm-Mut-seq for mapping mRNA 2′-O-methylation (Nm) (Cell Research (2023)); (4) Demethylation-Assisted Multiple Methylation sequencing (DAMM-seq, Nature Cell Biology (2021)) for simultaneous detection of m1A, m3C, m1G, and m22G methylations; (5) m7G-seq for mRNA internal m7G methylation (Molecular Cell (2019)). (6) LIME-seq for mapping dynamic RNA methylation in plasma cell-free RNA (Nature Biotechnology (2025)); (7) CRACI for quantitative base-resolution mapping of dihydrouridine (D) modifications in tRNA and mRNA (Nature Communications (2025)).